Shen J - Search Results

1

Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells.

Wang Q, Huang CH, Wibowo FS, Amin R, Shen J, Li F, Babu RJ. Wang Q, et al. Among authors: shen j. ACS Appl Mater Interfaces. 2024 Mar 20;16(11):13509-13524. doi: 10.1021/acsami.3c17792. Epub 2024 Mar 11. ACS Appl Mater Interfaces. 2024. PMID: 38466024

2

Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth.

Kang X, Wang Q, Wu S, Wang C, Annaji M, Huang CH, Shen J, Chen P, Babu RJ. Kang X, et al. Among authors: shen j. Biomolecules. 2023 Apr 25;13(5):744. doi: 10.3390/biom13050744. Biomolecules. 2023. PMID: 37238613 Free PMC article.

3

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.

Kang X, Jadhav S, Annaji M, Huang CH, Amin R, Shen J, Ashby CR Jr, Tiwari AK, Babu RJ, Chen P. Kang X, et al. Among authors: shen j. Pharmaceutics. 2023 May 23;15(6):1567. doi: 10.3390/pharmaceutics15061567. Pharmaceutics. 2023. PMID: 37376016 Free PMC article. Review.

4

Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.

Chang Y, Jiang J, Chen W, Yang W, Chen L, Chen P, Shen J, Qian S, Zhou T, Wu L, Hong L, Huang Y, Li F. Chang Y, et al. Among authors: shen j. Appl Mater Today. 2020 Mar;18:100492. doi: 10.1016/j.apmt.2019.100492. Epub 2019 Nov 7. Appl Mater Today. 2020. PMID: 34746366 Free PMC article.

5

The P2Y₂ receptor mediates terminal adipocyte differentiation and insulin resistance: Evidence for a dual G-protein coupling mode.

Qian S, Shi Y, Senfeld J, Peng Q, Shen J. Qian S, et al. Among authors: shen j. J Biol Chem. 2024 Feb;300(2):105589. doi: 10.1016/j.jbc.2023.105589. Epub 2023 Dec 21. J Biol Chem. 2024. PMID: 38141758 Free PMC article.

6

A purinergic mechanism underlying metformin regulation of hyperglycemia.

Senfeld J, Peng Q, Shi Y, Qian S, Shen J. Senfeld J, et al. Among authors: shen j. iScience. 2023 May 19;26(6):106898. doi: 10.1016/j.isci.2023.106898. eCollection 2023 Jun 16. iScience. 2023. PMID: 37378329 Free PMC article.

7

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer.

Shi Y, Riese DJ 2nd, Shen J. Shi Y, et al. Among authors: shen j. Front Pharmacol. 2020 Dec 8;11:574667. doi: 10.3389/fphar.2020.574667. eCollection 2020. Front Pharmacol. 2020. PMID: 33363463 Free PMC article. Review.

8

USP14 promotes K63-linked RIG-I deubiquitination and suppresses antiviral immune responses.

Li H, Zhao Z, Ling J, Pan L, Zhao X, Zhu H, Yu J, Xie B, Shen J, Chen W. Li H, et al. Among authors: shen j. Eur J Immunol. 2019 Jan;49(1):42-53. doi: 10.1002/eji.201847603. Epub 2018 Nov 28. Eur J Immunol. 2019. PMID: 30466171 Free article.

9

Functional evidence for biased inhibition of G protein signaling by YM-254890 in human coronary artery endothelial cells.

Peng Q, Alqahtani S, Nasrullah MZA, Shen J. Peng Q, et al. Among authors: shen j. Eur J Pharmacol. 2021 Jan 15;891:173706. doi: 10.1016/j.ejphar.2020.173706. Epub 2020 Nov 3. Eur J Pharmacol. 2021. PMID: 33152337 Free PMC article.

10

The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.

Lucas LM, Dwivedi V, Senfeld JI, Cullum RL, Mill CP, Piazza JT, Bryant IN, Cook LJ, Miller ST, Lott JH 4th, Kelley CM, Knerr EL, Markham JA, Kaufmann DP, Jacobi MA, Shen J, Riese DJ 2nd. Lucas LM, et al. Among authors: shen j. Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381. Pharmacol Rev. 2022. PMID: 34987087 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,718 results

Search Page